✦ LIBER ✦

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study

✍ Scribed by R. Ratner; M. Nauck; C. Kapitza; V. Asnaghi; M. Boldrin; R. Balena

Book ID: 110926949
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 285 KB
Volume: 27
Category: Article
ISSN: 0742-3071
DOI: 10.1111/j.1464-5491.2010.02990.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability of Once-Weekly Alendronate

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

✍ Greenspan, Susan; Field-Munves, Ellen; Tonino, Richard; Smith, Mary; Petruschke, 📂 Article 📅 2002 🏛 Mayo Clinic 🌐 English ⚖ 96 KB

Pharmacokinetic and pharmacodynamic prop

Pharmacokinetic and pharmacodynamic properties of taspoglutide, a once-weekly, human GLP-1 analogue, after single-dose administration in patients with Type 2 diabetes

✍ C. Kapitza; T. Heise; P. Birman; K. Jallet; J. Ramis; R. Balena 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Monotherapy with the once-weekly GLP-1 a

Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study

✍ G. Grunberger; A. Chang; G. Garcia Soria; F. T. Botros; R. Bsharat; Z. Milicevic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Monotherapy with the once-weekly GLP-1 a

✍ G. Grunberger; A. Chang; G. Garcia Soria; F. T. Botros; R. Bsharat; Z. Milicevic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Diabet. Med. 29, 1260–1267 (2012) ## Abstract **Aims** Evaluate dose‐dependent effects of once‐weekly dulaglutide, a glucagon‐like peptide‐1 analogue, on glycaemic control in patients with Type 2 diabetes treated with lifestyle measures with or without previous metformin. **Methods** This 12‐week

Dose-dependent effects of the once-daily

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

✍ R. E. Ratner; J. Rosenstock; G. Boka; on behalf of the DRI6012 Study Investigato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Pharmacology and tolerability of a singl

Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: A randomized, placebo-controlled, single-blind, dose-escalation, crossover study

✍ Jaret Malloy; Edmund Capparelli; Michael Gottschalk; Xuesong Guan; Prajakti Koth 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 145 KB